1,032
Participants
Start Date
December 1, 2017
Primary Completion Date
August 1, 2026
Study Completion Date
August 1, 2026
Oxaliplatin
oxaliplatin 130 mg/m2
Capecitabine
Capecitabine 1000mg/m2
Anqing Municipal Hospital, Anqing
Anhui Provincial Hospital, Hefei
First Affiliated Hospital of Wannan Medical College, Wuhu
Yuebei People's Hospital, Guangzhou
Shenzhen People's Hospital, Shenzhen
Jiangxi Provincial Cancer Hospital, Nanchang
Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou
Lishui Hospital of Zhejiang University, Lishui
Tianjin Medical University Cancer Institute and Hospital, Tianjin
Fudan University
OTHER